11:41 AM EST - Pediapharm Inc. : Has signed an exclusive licensing agreement with a company owned by Gerard Leduc, a globally known pharmaceutical executive for drug product Relaxa®. Under the terms of the Licensing Agreement, Pediapharm has the exclusive right to manufacture, promote, market, sell and distribute the Product globally. In return, Pediapharm will pay the Licensor royalties based on annual net sales of the Product. Pediapharm Inc.
shares V.PDP are trading up $0.02 at $0.28.
